|
Having trouble viewing this email? View it as a Web page.
STDs, the Genital Microbiome and HIV Transmission: What is Happening Down There? By Rupert Kaul, MD, PhD The Centers for Disease Control and Prevention’s Division of STD Prevention and the American Sexually Transmitted Diseases Association have partnered to bring you the latest research and best practices for STD prevention with the STD Prevention Science Series. Please join us on Thursday, March 10th from 1:00 pm – 2:00 pm ET for the next STD Prevention Science Series when Dr. Rupert Kaul discusses how the risk of sexual HIV transmission is dependent on the dynamic interaction between our immune system and microbes—both HIV, other STIs and the larger microbiome—at the mucosal surfaces of the genital tract and gut. He will also highlight some challenges of translating these research findings into new HIV prevention strategies. Dr. Rupert Kaul is dually trained as a clinical Infectious Disease specialist and a PhD immunologist, and is the director of the Infectious Diseases Division at the University of Toronto and University Health Network. His research is focused on the interaction between genital infections and mucosal immunology, and seeks to develop new ways to prevent and ameliorate HIV infection. This research is based in participant cohorts from Canada, Kenya, Uganda and South Africa, with the support of a University of Toronto/OHTN Endowed Chair in HIV Research. Attending the Presentation Participants can attend the STD Prevention Science Series in person in Building 8, Conference Room 1 A/B/C on the Corporate Square CDC Campus in Atlanta or by joining the event online and calling 800-619-7490. The conference number is PW7144391 and the participant passcode is 5929031. For more information visit www.astda.org.
|
